$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Efficacy and Tolerability of Triple‐Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: A Subgroup Analysis of Patients Stratified by Hypertension Severity, Age, Sex, and Obesity 원문보기

The journal of clinical hypertension, v.16 no.10, 2014년, pp.729 - 740  

Kreutz, Reinhold (Institute of Clinical Pharmacology and Toxicology Charité) ,  Ammentorp, Bettina (, Universtitä) ,  Laeis, Petra (tsmedizin –) ,  de la Sierra, Alejandro (Berlin Germany)

Abstract AI-Helper 아이콘AI-Helper

This prespecified subgroup analysis of a phase III study examined the effect of adding hydrochlorothiazide (HCTZ) to olmesartan (OLM)/amlodipine (AML) in patients with moderate to severe hypertension stratified by age, sex, body mass index, and hypertension severity. A total of 2690 patients, aged 1...

참고문헌 (33)

  1. 1 Stamler J , Stamler R , Neaton JD . Blood pressure, systolic and diastolic, and cardiovascular risks. US population data . Arch Intern Med. 1993 ; 153 : 598 ? 615 . 8439223 

  2. 2 Lewington S , Clarke R , Qizilbash N , et?al. Age­specific relevance of usual blood pressure to vascular mortality: a meta­analysis of individual data for one million adults in 61 prospective studies . Lancet. 2002 ; 360 : 1903 ? 1913 . 12493255 

  3. 3 Aronow WS , Fleg JL , Pepine CJ , et?al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents . Circulation. 2011 ; 123 : 2434 ? 2506 . 21518977 

  4. 4 Wald DS , Law M , Morris JK , et?al. Combination therapy versus monotherapy in reducing blood pressure: meta­analysis on 11,000 participants from 42 trials . Am J Med. 2009 ; 122 : 290 ? 300 . 19272490 

  5. 5 James PA , Oparil S , Carter BL , et?al. 2014 evidence­based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) . JAMA. 2014 ; 311 : 507 ? 520 . 24352797 

  6. 6 Mancia G , Fagard R , Narkiewicz K , et?al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) of the European Society of Cardiology (ESC) . J Hypertens. 2013 ; 31 : 1281 ? 1357 . 23817082 

  7. 7 Weber MA , Schiffrin EL , White WB , et?al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension . J Clin Hypertens (Greenwich). 2014 ; 16 : 14 ? 26 . 24341872 

  8. 8 Law MR , Morris JK , Wald NJ . Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta­analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies . BMJ. 2009 ; 338 : b1665 . 19454737 

  9. 9 Veterans Administration Cooperative Studies Program . Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg . JAMA. 1967 ; 202 : 1028 ? 1034 . 4862069 

  10. 10 Bramley TJ , Gerbino PP , Nightengale BS , Frech­Tamas F . Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations . J Manag Care Pharm. 2006 ; 12 : 239 ? 245 . 16623608 

  11. 11 Corrao G , Parodi A , Nicotra F , et?al. Better compliance to antihypertensive medications reduces cardiovascular risk . J Hypertens. 2011 ; 29 : 610 ? 618 . 21157368 

  12. 12 Kettani FZ , Dragomir A , Cote R , et?al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention . Stroke. 2009 ; 40 : 213 ? 220 . 19038916 

  13. 13 Perreault S , Dragomir A , Roy L , et?al. Adherence level of antihypertensive agents in coronary artery disease . Br J Clin Pharmacol. 2010 ; 69 : 74 ? 84 . 20078615 

  14. 14 Perreault S , Dragomir A , White M , et?al. Better adherence to antihypertensive agents and risk reduction of chronic heart failure . J Intern Med. 2009 ; 266 : 207 ? 218 . 19623691 

  15. 15 Oparil S , Melino M , Lee J , et?al. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: the TRINITY multicenter, randomized, double­blind, 12­week, parallel­group study . Clin Ther. 2010 ; 32 : 1252 ? 1269 . 20678674 

  16. 16 Volpe M , Rump LC , Ammentorp B , Laeis P . Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination . Clin Drug Investig. 2012 ; 32 : 649 ? 664 . 

  17. 17 Mancia G , De Backer G , Dominiczak A , et?al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) of the European Society of Cardiology (ESC) . J Hypertens. 2007 ; 25 : 1105 ? 1187 . 17563527 

  18. 18 Mancia G , Laurent S , Agabiti­Rosei E , et?al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document . J Hypertens. 2009 ; 27 : 2121 ? 2158 . 19838131 

  19. 19 Schmieder RE , Bohm M . Efficacy and safety of olmesartan medoxomil plus amlodipine in age, gender and hypertension severity defined subgroups of hypertensive patients . J Hum Hypertens. 2011 ; 25 : 354 ? 363 . 20686499 

  20. 20 Weycker D , Edelsberg J , Vincze G , et?al. Blood pressure control in patients initiating antihypertensive therapy . Ann Pharmacother. 2008 ; 42 : 169 ? 176 . 18182472 

  21. 21 de la Sierra A , Ammentorp B , Laeis P . Effect of long­term treatment with the triple olmesartan (O)/amlodipine (A)/hydrochlorothiazide (H) combination on hypertension severity . J Hypertens. 2012 ; 30 ( e suppl A ): e276 . 

  22. 22 Kereiakes DJ , Chrysant SG , Izzo JL Jr , et?al. Long­term efficacy and safety of triple­combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension . J Clin Hypertens (Greenwich). 2012 ; 14 : 149 ? 157 . 22372774 

  23. 23 Calhoun DA , Lacourciere Y , Chiang YT , Glazer RD . Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial . Hypertension. 2009 ; 54 : 32 ? 39 . 19470877 

  24. 24 Chrysant SG , Izzo JL Jr , Kereiakes DJ , et?al. Efficacy and safety of triple­combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: a subpopulation analysis of the TRINITY study . J Am Soc Hypertens. 2012 ; 6 : 132 ? 141 . 22030597 

  25. 25 Kereiakes DJ , Chrysant SG , Izzo JL Jr , et?al. Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double­blind, parallel­group TRINITY study . Cardiovasc Diabetol. 2012 ; 11 : 134 . 23110471 

  26. 26 Chrysant SG , Littlejohn T 3rd , Izzo JL Jr , et?al. Triple­combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non­black study participants with hypertension: the TRINITY randomized, double­blind, 12­week, parallel­group study . Am J Cardiovasc Drugs. 2012 ; 12 : 233 ? 243 . 22799613 

  27. 27 Lewin AJ , Kereiakes DJ , Chrysant SG , et?al. Triple­combination treatment with olmesartan medoxomil/amlodipine/hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study . Ethn Dis. 2014 ; 24 : 41 ? 47 . 24620447 

  28. 28 Lewin AJ , Izzo JL Jr , Melino M , et?al. Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age . Drugs Aging. 2013 ; 30 : 549 ? 560 . 23549909 

  29. 29 Roth EM , Oparil S , Melino M , et?al. Olmesartan/amlodipine/hydrochlorothiazide in obese participants with hypertension: a TRINITY subanalysis . J Clin Hypertens (Greenwich). 2013 ; 15 : 584 ? 592 . 23889722 

  30. 30 Gerbino PP , Shoheiber O . Adherence patterns among patients treated with fixed­dose combination versus separate antihypertensive agents . Am J Health Syst Pharm. 2007 ; 64 : 1279 ? 1283 . 17563050 

  31. 31 Landsberg L , Aronne LJ , Beilin LJ , et?al. Obesity­related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of the Obesity Society and the American Society of Hypertension . J Clin Hypertens (Greenwich). 2013 ; 15 : 14 ? 33 . 23282121 

  32. 32 Sherrill B , Halpern M , Khan S , et?al. Single­pill vs free­equivalent combination therapies for hypertension: a meta­analysis of health care costs and adherence . J Clin Hypertens (Greenwich). 2011 ; 13 : 898 ? 909 . 22142349 

  33. 33 Gupta AK , Arshad S , Poulter NR . Compliance, safety, and effectiveness of fixed­dose combinations of antihypertensive agents: a meta­analysis . Hypertension. 2010 ; 55 : 399 ? 407 . 20026768 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD(Hybrid)

저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로